• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arthritis Rheumatol Mild Course of Coronavirus Disease 2019 and Spontaneous Severe Acute Respiratory Syndrome Coronavirus 2 Clearance in a Patient Wi

tetano

Editor, Senior Moderator
Arthritis Rheumatol


. 2020 May 26.
doi: 10.1002/art.41380. Online ahead of print.
Mild Course of Coronavirus Disease 2019 and Spontaneous Severe Acute Respiratory Syndrome Coronavirus 2 Clearance in a Patient With Depleted Peripheral Blood B-cells Due to Treatment With Rituximab


Benedict Fallet[SUP] 1 [/SUP], Diego Kyburz[SUP] 1 [/SUP], Ulrich A Walker[SUP] 1 [/SUP]



Affiliations

Abstract

Over 4 million cases of Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been confirmed worldwide. Up to 20% of cases develop severe disease and the fatality rate are high.[1] Little is known however on the course of the infection in immunosuppressed patients. We therefore report the case of a patient with COVID-19 under immunosuppression with rituximab. This 77-year-old woman was admitted to the hospital with a 5-week history of unclear fever (up to 38.5?C), hypotension (80 mmHg systolic on self-measurement), occasional mild shortness of breath and intermittent dry cough.
 
Back
Top Bottom